HROW
Harrow, Inc. trades as HROW and has a market capitalization of $1.39 B, making it the #2389 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $272.30M, up 36.4% from the prior year and net income of -$5.14M. This page tracks Harrow, Inc. through 849 SEC filings, with financial statements and metrics updated as new reports are filed.
Over the last 9 fiscal years Harrow, Inc.'s revenue grew from $19.94M to $272.30M, a compound annual growth rate of 33.7%. Net profit margin expanded from -95.7% to -1.9% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-19 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-15 |
| Insider trade | 4 | 2026-05-15 |
| Quarterly report | 10-Q | 2026-05-11 |
| SCHEDULE 13G/A | - | 2026-05-11 |
| Major company event | 8-K | 2026-05-11 |
Harrow to Present at William Blair’s 46th Annual Growth Stock Conference | Harrow, Inc.
Harrow Announces First Quarter 2026 Financial Results | Harrow, Inc.
Participants can access the live webcast of Harrow’s presentation on the “Investors” page of Harrow’s website. A replay of the webcast will be available on the Company’s website for one year.
Harrow Announces the Issuance of J-Code for IOPIDINE® 1% | Harrow, Inc.
Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 | Harrow, Inc.
The largest companies sharing Harrow, Inc.'s SEC industry classification (pharmaceutical preparations).
Harrow, Inc. (HROW) has a market capitalization of $1.39 B as of 2026-06-10, ranking #2389 among US-listed companies.
Harrow, Inc. reported revenue of $272.30M for fiscal year 2025, an increase of 36.4% year over year.
In its latest fiscal year Harrow, Inc. reported a net loss of $5.14M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.